ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal-Bolus Regimens for Type 2 Diabetes in the UK.

Richard F Pollock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.